List of Tables
Table 1. Global Dual Orexin Receptor Antagonist Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Dual Orexin Receptor Antagonist Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Dual Orexin Receptor Antagonist Market Competitive Situation by Manufacturers in 2025
Table 4. Global Dual Orexin Receptor Antagonist Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Dual Orexin Receptor Antagonist Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Dual Orexin Receptor Antagonist Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Dual Orexin Receptor Antagonist Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Dual Orexin Receptor Antagonist, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Dual Orexin Receptor Antagonist, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Dual Orexin Receptor Antagonist, Product Types and Applications
Table 12. Global Key Manufacturers of Dual Orexin Receptor Antagonist, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dual Orexin Receptor Antagonist Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dual Orexin Receptor Antagonist Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dual Orexin Receptor Antagonist Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Dual Orexin Receptor Antagonist Sales by Region (K Units), 2021–2026
Table 18. Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2021–2026)
Table 19. Global Dual Orexin Receptor Antagonist Sales by Region (K Units), 2027–2032
Table 20. Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2027–2032)
Table 21. Global Dual Orexin Receptor Antagonist Revenue by Region (US$ Million), 2021–2026
Table 22. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2021–2026)
Table 23. Global Dual Orexin Receptor Antagonist Revenue by Region (US$ Million), 2027–2032
Table 24. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2027–2032)
Table 25. North America Dual Orexin Receptor Antagonist Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Dual Orexin Receptor Antagonist Sales by Country (K Units), 2021–2026
Table 27. North America Dual Orexin Receptor Antagonist Sales by Country (K Units), 2027–2032
Table 28. North America Dual Orexin Receptor Antagonist Revenue by Country (US$ Million), 2021–2026
Table 29. North America Dual Orexin Receptor Antagonist Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Dual Orexin Receptor Antagonist Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Dual Orexin Receptor Antagonist Sales by Country (K Units), 2021–2026
Table 32. Europe Dual Orexin Receptor Antagonist Sales by Country (K Units), 2027–2032
Table 33. Europe Dual Orexin Receptor Antagonist Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Dual Orexin Receptor Antagonist Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Dual Orexin Receptor Antagonist Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Dual Orexin Receptor Antagonist Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Dual Orexin Receptor Antagonist Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Dual Orexin Receptor Antagonist Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Dual Orexin Receptor Antagonist Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Dual Orexin Receptor Antagonist Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Dual Orexin Receptor Antagonist Sales by Country (K Units), 2021–2026
Table 42. Latin America Dual Orexin Receptor Antagonist Sales by Country (K Units), 2027–2032
Table 43. Latin America Dual Orexin Receptor Antagonist Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Dual Orexin Receptor Antagonist Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Dual Orexin Receptor Antagonist Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Dual Orexin Receptor Antagonist Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Dual Orexin Receptor Antagonist Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Dual Orexin Receptor Antagonist Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Dual Orexin Receptor Antagonist Revenue by Country (US$ Million), 2027–2032
Table 50. Global Dual Orexin Receptor Antagonist Sales (K Units) by Type (2021–2026)
Table 51. Global Dual Orexin Receptor Antagonist Sales (K Units) by Type (2027–2032)
Table 52. Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2021–2026)
Table 53. Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2027–2032)
Table 54. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2021–2026)
Table 57. Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2027–2032)
Table 58. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Type (2021–2026)
Table 59. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Type (2027–2032)
Table 60. Global Dual Orexin Receptor Antagonist Sales (K Units) by Application (2021–2026)
Table 61. Global Dual Orexin Receptor Antagonist Sales (K Units) by Application (2027–2032)
Table 62. Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2021–2026)
Table 63. Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2027–2032)
Table 64. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Dual Orexin Receptor Antagonist Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2021–2026)
Table 67. Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2027–2032)
Table 68. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Application (2021–2026)
Table 69. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Dual Orexin Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Merck Dual Orexin Receptor Antagonist Product
Table 74. Merck Recent Developments/Updates
Table 75. Eisal Company Information
Table 76. Eisal Description and Business Overview
Table 77. Eisal Dual Orexin Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eisal Dual Orexin Receptor Antagonist Product
Table 79. Eisal Recent Developments/Updates
Table 80. Idorsia Company Information
Table 81. Idorsia Description and Business Overview
Table 82. Idorsia Dual Orexin Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Idorsia Dual Orexin Receptor Antagonist Product
Table 84. Idorsia Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Dual Orexin Receptor Antagonist Distributors List
Table 88. Dual Orexin Receptor Antagonist Customers List
Table 89. Dual Orexin Receptor Antagonist Market Trends
Table 90. Dual Orexin Receptor Antagonist Market Drivers
Table 91. Dual Orexin Receptor Antagonist Market Challenges
Table 92. Dual Orexin Receptor Antagonist Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dual Orexin Receptor Antagonist
Figure 2. Global Dual Orexin Receptor Antagonist Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Dual Orexin Receptor Antagonist Market Share by Type: 2025 & 2032
Figure 4. Suvorexant Product Picture
Figure 5. Lemborexant Product Picture
Figure 6. Daridorexant Product Picture
Figure 7. Global Dual Orexin Receptor Antagonist Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Dual Orexin Receptor Antagonist Market Share by Application: 2025 & 2032
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Dual Orexin Receptor Antagonist Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Dual Orexin Receptor Antagonist Market Size (US$ Million), 2021–2032
Figure 14. Global Dual Orexin Receptor Antagonist Sales (K Units), 2021–2032
Figure 15. Global Dual Orexin Receptor Antagonist Average Price (US$/Unit), 2021–2032
Figure 16. Dual Orexin Receptor Antagonist Report Years Considered
Figure 17. Dual Orexin Receptor Antagonist Sales Share by Manufacturers in 2025
Figure 18. Global Dual Orexin Receptor Antagonist Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Dual Orexin Receptor Antagonist Players: Market Share by Revenue in Dual Orexin Receptor Antagonist in 2025
Figure 20. Dual Orexin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Dual Orexin Receptor Antagonist Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Dual Orexin Receptor Antagonist Sales Market Share by Country (2021–2032)
Figure 23. North America Dual Orexin Receptor Antagonist Revenue Market Share by Country (2021–2032)
Figure 24. United States Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Dual Orexin Receptor Antagonist Sales Market Share by Country (2021–2032)
Figure 27. Europe Dual Orexin Receptor Antagonist Revenue Market Share by Country (2021–2032)
Figure 28. Germany Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Dual Orexin Receptor Antagonist Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Dual Orexin Receptor Antagonist Revenue Market Share by Region (2021–2032)
Figure 35. China Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Dual Orexin Receptor Antagonist Sales Market Share by Country (2021–2032)
Figure 43. Latin America Dual Orexin Receptor Antagonist Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Dual Orexin Receptor Antagonist Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Dual Orexin Receptor Antagonist Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Dual Orexin Receptor Antagonist Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Dual Orexin Receptor Antagonist by Type (2021–2032)
Figure 54. Global Revenue Market Share of Dual Orexin Receptor Antagonist by Type (2021–2032)
Figure 55. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Dual Orexin Receptor Antagonist by Application (2021–2032)
Figure 57. Global Revenue Market Share of Dual Orexin Receptor Antagonist by Application (2021–2032)
Figure 58. Global Dual Orexin Receptor Antagonist Price (US$/Unit) by Application (2021–2032)
Figure 59. Dual Orexin Receptor Antagonist Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
